ストックスクリーナーアプリを入手
6.34
6.11%
0.365
アフターアワーズ：
6.30
-0.04
-0.63%
前日終値:
$5.975
開ける：
$6.05
24時間の取引高:
10.23M
Relative Volume:
1.71
時価総額：
$1.02B
収益：
$847.25M
当期純損益:
$-284.86M
株価収益率:
-2.7686
EPS:
-2.29
ネットキャッシュフロー:
$-112.35M
1週間 パフォーマンス:
+1.12%
1か月 パフォーマンス:
+8.19%
6か月 パフォーマンス:
-25.06%
1年 パフォーマンス:
-28.60%
1日の値動き範囲:
$6.04
$6.45
1週間の範囲:
$5.80
$7.50
52週間の値動き範囲:
$5.01
$23.86
Novavax Inc Stock (NVAX) Company Profile
NVAX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NVAX
Novavax Inc
|
6.34 | 1.02B | 847.25M | -284.86M | -112.35M | -2.29 |
|
VRTX
Vertex Pharmaceuticals Inc
|
439.37 | 128.45B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
575.63 | 65.17B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
560.90 | 40.09B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
270.19 | 35.67B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
233.25 | 27.44B | 3.81B | -644.79M | -669.77M | -6.24 |
Novavax Inc Stock (NVAX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-02-28 | 開始されました | BTIG Research | Buy |
| 2024-07-30 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2024-05-10 | アップグレード | BofA Securities | Underperform → Neutral |
| 2024-05-10 | アップグレード | JP Morgan | Underweight → Neutral |
| 2023-08-09 | アップグレード | B. Riley Securities | Neutral → Buy |
| 2023-04-20 | ダウングレード | TD Cowen | Outperform → Market Perform |
| 2023-03-01 | ダウングレード | B. Riley Securities | Buy → Neutral |
| 2023-01-09 | 繰り返されました | B. Riley Securities | Buy |
| 2022-12-30 | 繰り返されました | H.C. Wainwright | Buy |
| 2022-12-02 | 開始されました | Jefferies | Hold |
| 2022-09-22 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2022-05-20 | 開始されました | BofA Securities | Underperform |
| 2022-02-23 | 繰り返されました | B. Riley Securities | Buy |
| 2022-02-22 | 再開されました | Jefferies | Buy |
| 2022-01-21 | 開始されました | Cowen | Outperform |
| 2021-05-12 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2020-12-14 | 開始されました | Jefferies | Buy |
| 2020-08-06 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-08-05 | アップグレード | JP Morgan | Neutral → Overweight |
| 2020-08-05 | ダウングレード | Ladenburg Thalmann | Neutral → Sell |
| 2020-07-16 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-07-08 | ダウングレード | Ladenburg Thalmann | Buy → Neutral |
| 2020-06-29 | 繰り返されました | B. Riley FBR | Buy |
| 2020-06-29 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-06-05 | アップグレード | JP Morgan | Underweight → Neutral |
| 2020-05-28 | 繰り返されました | B. Riley FBR | Buy |
| 2020-05-12 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-04-30 | 繰り返されました | H.C. Wainwright | Buy |
| 2019-11-27 | 再開されました | B. Riley FBR | Buy |
| 2019-08-14 | 繰り返されました | H.C. Wainwright | Buy |
| 2019-02-28 | ダウングレード | Piper Jaffray | Overweight → Underweight |
| 2018-12-18 | 開始されました | Ladenburg Thalmann | Buy |
| 2018-12-11 | 開始されました | Oppenheimer | Outperform |
| 2018-11-26 | アップグレード | Piper Jaffray | Neutral → Overweight |
| 2018-09-21 | アップグレード | JP Morgan | Underweight → Overweight |
| 2018-03-29 | アップグレード | Seaport Global Securities | Neutral → Buy |
すべてを表示
Novavax Inc (NVAX) 最新ニュース
Novavax: Initiating Hold Rating After Strong, But Misunderstood Q1 2025 Earnings Beat - Seeking Alpha
JP Morgan Lowers Price Target for NVAX, Maintains Underweight Ra - GuruFocus
Novavax First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Benzinga Bulls And Bears: IBM, Novavax, Arm Holdings — And UK Trade Deal Boosts Markets - Benzinga
JP Morgan Lowers Price Target for NVAX, Maintains Underweight Rating | NVAX Stock News - GuruFocus
Why Novavax (NVAX) is a Top Momentum Stock for the Long-Term - Yahoo Finance
NVAX Stock Gains 12% on Q1 Earnings & Sales Beat, '25 Sales View Up - Yahoo Finance
Analysts Just Shipped An Incredible Upgrade To Their Novavax, Inc. (NASDAQ:NVAX) Estimates - Yahoo Finance
Novavax (NVAX) Faces Price Target Cut Amid Regulatory Concerns | NVAX Stock News - GuruFocus
Novavax: Q1 Earnings Snapshot - New Haven Register
Novavax Inc (NVAX) Q1 2025 Earnings Call Highlights: Revenue Surge Amid Strategic Partnerships ... - Yahoo Finance
Novavax Inc (NVAX) Q1 2025 Earnings Call Highlights: Revenue Sur - GuruFocus
Novavax Inc (NVAX) Q1 2025 Earnings Call Highlights: Revenue Surge Amid Strategic Partnerships ... By GuruFocus - Investing.com Canada
Decoding Novavax Inc (NVAX): A Strategic SWOT Insight - GuruFocus
Novavax (NVAX) Sets Sights on Profitability with Strategic Shifts - GuruFocus
Novavax (NVAX) Shares Surge After Upbeat Q1 Results and Raised R - GuruFocus
Health Care Stocks See Mixed Results In Market Movements - Finimize
Novavax projects $1.025B 2025 revenue framework with focus on partnerships - MSN
Novavax (NVAX) Eyes Resolution with FDA for Covid Vaccine Approval | NVAX Stock News - GuruFocus
Novavax says talks with FDA on COVID vaccine approval ongoing calming investor fears - Reuters
Why This Shrinking Covid-19 Vaccine Stock Jumped 30% - Barron's
COVID Vaccine Maker Novavax Stock Soars 16%Here's Why - Yahoo Finance
Novavax Q1 2025 slides: Revenue surges to $667M, company raises full-year guidance By Investing.com - Investing.com South Africa
Novavax (NVAX) Set to Release Q1 Earnings with Strong Revenue Gr - GuruFocus
FDA advisory panel to discuss makeup of updated COVID shots - Seeking Alpha
Novavax Hauls in $666M Q1 Windfall, Boosts FY25 Outlook - Yahoo Finance
Thursday's Top 5 Trending Stocks: What's Going On With D-Wave, Novavax, Carvana? - Benzinga
Novavax Stock Rallies On Upbeat Q1 Earnings, Revised Full-Year Revenue Forecast: Retail’s Elated By Stocktwits - Investing.com India
Earnings call transcript: Novavax Q1 2025 Surpasses Expectations with Strong Revenue Growth - Investing.com
Novavax Stock Rallies On Upbeat Q1 Earnings, Revised Full-Year Revenue Forecast: Retail’s Elated - MSN
Novavax earnings beat by $3.36, revenue topped estimates - Investing.com
Novavax stock soars 20% as Q1 results crush estimates By Investing.com - Investing.com Australia
Novavax swings to profit on lower expenses related to COVID shots - WHTC
Novavax rises after massive Q1 beat, guidance raise - MSN
Novavax (NVAX) Beats Q1 Earnings and Revenue Estimates - Yahoo Finance
NVAX Earnings: Novavax Stock Soars 33% in Pre-Market on Explosive Q1 Profit - TipRanks
Novavax Q1 2025 slides: Revenue surges to $667M, company raises full-year guidance - Investing.com Australia
Novavax (NVAX) Reports Strong Q1 Earnings Boosted by APA Terminations - GuruFocus
Novavax (NVAX) Exceeds Q1 Expectations with Strong Earnings and Revenue - GuruFocus
Novavax (NVAX) Shares Surge After Upbeat Q1 Results and Raised Revenue Outlook - GuruFocus
Novavax Inc. Q1 2025 Earnings: EPS of $0.71, Revenue Surges to $667 Million, Exceeding Estimates - GuruFocus
Novavax jumps after vaccine maker swings to profit in first quarter - TradingView
Earnings snapshot: Novavax Q1 tops estimates; updates FY25 outlook - Seeking Alpha
Novavax Reports First Quarter 2025 Financial Results and Operational Highlights | NVAX Stock News - GuruFocus
Novavax Swings To Profit As COVID-19 Vaccine Costs Drop - Finimize
NOVAVAX INC SEC 10-Q Report - TradingView
Novavax Reports First Quarter 2025 Financial Results and Operational Highlights - PR Newswire
Novavax, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
Novavax to Report First Quarter 2025 Financial Results on May 8, 2025 - Longview News-Journal
US FDA advisers to discuss COVID-19 vaccine recommendations on May 22 - marketscreener.com
Novavax Inc (NVAX) 財務データ
収益
当期純利益
現金流量
EPS
4.10%
大文字化:
|
ボリューム (24 時間):